| Completed | Study to Evaluate ASN008 Topical Gel (TG) Dermatitis, Atopic, Pruritus, Dermatitis Eczema | Phase 1 | 2019-01-14 |
| Completed | Study to Evaluate ASN002 in Subjects With Moderate To Severe Chronic Hand Eczema Chronic Hand Dermatitis | Phase 2 | 2019-01-03 |
| Completed | Phase 1 Study to Evaluate ASN002 Absorption, Metabolism, and Excretion of [14C] Following a Single Oral Dose i Healthy Volunteer | Phase 1 | 2018-10-11 |
| Terminated | Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis Atopic Dermatitis | Phase 2 | 2018-09-29 |
| Completed | Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT) Atopic Dermatitis | Phase 2 | 2018-07-05 |
| Completed | A Study of ASN007 in Patients With Advanced Solid Tumors Cancer, Malignancy, Neoplasia | Phase 1 | 2018-01-19 |
| Completed | A Study To Evaluate ASN002 In Subjects With Atopic Dermatitis Dermatitis, Atopic, Dermatitis Eczema, Dermatitis, Eczematous | Phase 1 | 2017-04-12 |
| Terminated | Study of ASN003 in Subjects With Advanced Solid Tumors Neoplasms, Melanoma, Colorectal Neoplasm | Phase 1 | 2016-10-01 |
| Completed | Single Ascending Dose Study to Evaluate Pharmacokinetics and Food-Effect in Healthy Volunteers Healthy Volunteers | Phase 1 | 2016-07-01 |
| Terminated | A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Follicular | Phase 1 / Phase 2 | 2015-05-01 |
| Terminated | Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer Cancer of the Prostate, Neoplasms, Prostate, Prostate Cancer | Phase 1 | 2015-01-19 |